How to prevent pulmonary cerebral disease?

The prevention of pulmonary cerebral diseases begins in the following areas:I. Management of lung diseasesChronic obstructive pulmonary disease (COPD) management1. Stop smoking: Smoking is a major risk factor for the COP, and it can effectively slow down the progress of the COP. For smoking patients, smoking cessation counselling and assisted smoking cessation measures, such as nicotine substitution therapy (using nicotine stickers, gum, etc.) should be provided.2. Regular treatment: COPD patients need regular and permanent use of drugs to control their condition. For example, inhalation of bronchial expansionants (salbutamol, ammonium isopropobromine, etc.) can ease the bronchial and improve the air flow. There may also be a need for co-use of sugar-coated hormones (e.g., Boudinaid) to mitigate respiratory inflammation in patients with more severe conditions. Patients should undergo regular visits, in strict compliance with medical prescriptions, and adapt treatment programmes to the situation.3. Rehabilitation exercise: includes respiratory and body exercise. Respiration and abdominal respiration are common methods of respiratory activity. When a condensed lip breathes, the patient breathes through his nose, then condensed his lips into a whistling-like slow exhale, which is two to three times the inhaling time, which increases the exhalation exhaust pressure and prevents the premature collapse of the small airway. The abdominal respiration allows the patient to flatten or half-bed, to place one hand in the chest, the other in the abdomen, when inhaled by the nose, the abdominal rises, the abdominal contractions when exhales, and the respiration is enhanced by the movement of the muscular muscles. Full body exercise, such as walking, Tai Chi Fist, can improve patients ‘ endurance and CPR function.Pneumonia prevention and treatmentVaccination: Pneumonia vaccinations are effective in preventing pneumonia among high-risk groups such as the elderly and the less immune population. Pneumococcal vaccine is a common type of vaccine that reduces the incidence of pneumococcal infections leading to pneumonia.2. Prevention of exposure to sources of infection: Take care of personal hygiene, wash hands and avoid exposure to people with respiratory infections. During the high-prevalence flu season, it is possible to minimize the number of densely populated sites and to wear masks if necessary.3. Active treatment: Should pneumonia occur, it should be treated in a timely manner. The appropriate antibiotics are selected according to pathogen type, i.e., for community access to pneumocococcal infections, common penicillin or precipitin-like antibiotics, and in the case of secondary infections, the Great Ringed ester-type antibiotics (e.g., Archicin). At the same time, care must be taken to rest, to ensure nutritional intake and to promote the reduction of pneumonia.Prevention of pulmonary heart disease1. Control of basic pulmonary diseases: As mentioned earlier, active treatment of lung diseases that cause pulmonary heart disease (e.g. COPD, pulmonary fibrosis, etc.) is key. Progress in control of pulmonary diseases reduces the risk of pulmonary heart disease by reducing pulmonary arterial pressure.2. Monitoring of the heart function: For patients already suffering from pulmonary heart disease, the heart function is regularly monitored, including EKG, heart ultrasound, etc. These checks allow for timely detection of changes in the function of the right heart, e.g., in the case of the right heart chamber, which is obese, and the increase in lung arteries. In the case of signs of heart failure, treatment should be provided in a timely manner, such as the use of urinants (e.g. HCl, propyl) to reduce oedema and improve the front load of the heart.II. Improved respiratory function and oxidation1. Home oxygen therapyLong-term home oxygen therapy is an important preventive measure for patients with chronic respiratory failure. Oxygen is generally used for nose catheters, with an oxygen flow of 1-2L/min and an oxygen intake of not less than 15 hours per day. Home-based oxygen therapy increases the saturation of the patient ‘ s blood and reduces the adverse effects of oxygen deficiency on the body, including damage to the brain. Patients and family members should have the correct oxygen-absorption methods and care, and should regularly check the oxygen-absorption equipment to ensure its proper functioning.2. Respiratory function monitoringPatients can regularly monitor blood oxygen saturation (Spo2). SpO2 should normally remain above 90 per cent. If SpO2 is below this value, it may indicate a decline in respiratory function, requiring a timely adjustment of treatment options such as increased oxygen use or timely medical access. It is also important to observe changes in the frequency, rhythm and depth of breathing. Attention should be given to cases of rapid, slow or irregular breathing.III. Maintenance of internal environmental stability and nutritional supportElectrolyte and acid alkali balancePeriodic checks of electrolyte and alkali balance. Electrolytic disorders (e.g., potassium, sodium, etc.) and acid imbalance (e.g., respiratory acid poisoning) may result from the use of urinants, respiratory disorders, etc. for some patients with lung diseases. The timely correction of these anomalies is essential to maintain normal physical functioning and to prevent pulmonary cerebral disease. For example, in the case of persons with low potassium haemorrhagic disorders, it can be corrected by oral or intravenous potassium.2. Nutritional supportAdequate nutrients, including proteins, carbohydrates, fats, vitamins and minerals, are guaranteed. Malnutrition leads to respiratory weakness and lower respiratory function. For those who are able to feed on their own, they should be encouraged to consume nutritious foods such as skinny meat, fish, eggs, fresh vegetables and fruit. Nutritional support may be required, for example, through nasal feed, for patients who cannot feed themselves.Persons with chronic obstructive pulmonary diseases, bronchial asthma, etc. have adopted the above measures with a view to reducing the incidence of pulmonary cerebral disease and improving the quality of life.